Molecular and cellular signatures underlying superior immunity against Bordetella pertussis upon pulmonary vaccination.
Cast your vote
You can rate an item by clicking the amount of stars they wish to award to this item.
When enough users have cast their vote on this item, the average rating will also be shown.
Your vote was cast
Thank you for your feedback
Thank you for your feedback
AuthorsRaeven, R Hm
Pennings, J LA
van der Maas, L
van der Ark, A
van der Ley, P
van Eden, W
van Riet, E
van Els, C Acm
Kersten, G Fa
Han, W Gh
MetadataShow full item record
TitleMolecular and cellular signatures underlying superior immunity against Bordetella pertussis upon pulmonary vaccination.
Published inMucosal Immunol 2017, advance online publication (ahead of print)
PubliekssamenvattingMucosal immunity is often required for protection against respiratory pathogens but the underlying cellular and molecular mechanisms of induction remain poorly understood. Here, systems vaccinology was used to identify immune signatures after pulmonary or subcutaneous immunization of mice with pertussis outer membrane vesicles. Pulmonary immunization led to improved protection, exclusively induced mucosal immunoglobulin A (IgA) and T helper type 17 (Th17) responses, and in addition evoked elevated systemic immunoglobulin G (IgG) antibody levels, IgG-producing plasma cells, memory B cells, and Th17 cells. These adaptive responses were preceded by unique local expression of genes of the innate immune response related to Th17 (e.g., Rorc) and IgA responses (e.g., Pigr) in addition to local and systemic secretion of Th1/Th17-promoting cytokines. This comprehensive systems approach identifies the effect of the administration route on the development of mucosal immunity, its importance in protection against Bordetella pertussis, and reveals potential molecular correlates of vaccine immunity to this reemerging pathogen.Mucosal Immunology advance online publication 20 September 2017; doi:10.1038/mi.2017.81.
- Intranasal immunization with outer membrane vesicle pertussis vaccine confers broad protection through mucosal IgA and Th17 responses.
- Authors: Raeven RHM, Rockx-Brouwer D, Kanojia G, van der Maas L, Bindels THE, Ten Have R, van Riet E, Metz B, Kersten GFA
- Issue date: 2020 Apr 30
- Relative contribution of Th1 and Th17 cells in adaptive immunity to Bordetella pertussis: towards the rational design of an improved acellular pertussis vaccine.
- Authors: Ross PJ, Sutton CE, Higgins S, Allen AC, Walsh K, Misiak A, Lavelle EC, McLoughlin RM, Mills KH
- Issue date: 2013
- Sustained protective immunity against Bordetella pertussis nasal colonization by intranasal immunization with a vaccine-adjuvant combination that induces IL-17-secreting T<sub>RM</sub> cells.
- Authors: Allen AC, Wilk MM, Misiak A, Borkner L, Murphy D, Mills KHG
- Issue date: 2018 Nov
- Immunological Signatures after Bordetella pertussis Infection Demonstrate Importance of Pulmonary Innate Immune Cells.
- Authors: Raeven RH, Brummelman J, van der Maas L, Tilstra W, Pennings JL, Han WG, van Els CA, van Riet E, Kersten GF, Metz B
- Issue date: 2016
- Development of a thermostable spray dried outer membrane vesicle pertussis vaccine for pulmonary immunization.
- Authors: Kanojia G, Raeven RHM, van der Maas L, Bindels THE, van Riet E, Metz B, Soema PC, Ten Have R, Frijlink HW, Amorij JP, Kersten GFA
- Issue date: 2018 Sep 28